Literature DB >> 26868102

Addressing Skyrocketing Cancer Drug Prices Comes With Tradeoffs: Pick Your Poison.

Scott D Ramsey1, Gary H Lyman1, Rick Bangs2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26868102     DOI： 10.1001/jamaoncol.2015.5813

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  6 in total

1.  Cost-Savings Analysis of AR-V7 Testing in Patients With Metastatic Castration-Resistant Prostate Cancer Eligible for Treatment With Abiraterone or Enzalutamide.

Authors:  Mark C Markowski; Kevin D Frick; James R Eshleman; Jun Luo; Emmanuel S Antonarakis
Journal:  Prostate       Date:  2016-07-12       Impact factor: 4.104

2.  Dynamic Assessment of Value During High-Cost Cancer Treatment: A Response to American Society of Clinical Oncology and European Society of Medical Oncology.

Authors:  Charles W Given; Barbara A Given; Cathy J Bradley; John C Krauss; Alla Sikorskii; Eric Vachon
Journal:  J Oncol Pract       Date:  2016-10-31       Impact factor: 3.840

3.  Rising Prices of Targeted Oral Anticancer Medications and Associated Financial Burden on Medicare Beneficiaries.

Authors:  Ya-Chen Tina Shih; Ying Xu; Lei Liu; Fabrice Smieliauskas
Journal:  J Clin Oncol       Date:  2017-05-04       Impact factor: 44.544

4.  Close cooperation with Health Technology Assessment expertise is crucial for implementation and ultimately reimbursement of innovations in oncology.

Authors:  W H van Harten; V P Retèl
Journal:  Ecancermedicalscience       Date:  2016-10-28

5.  Cancer Drug Pricing and Reimbursement: Lessons for the United States From Around the World.

Authors:  Daniel A Goldstein; Michal Sarfaty
Journal:  Oncologist       Date:  2016-07-06

6.  Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy.

Authors:  Francesco Trotta; Flavia Mayer; Francesco Barone-Adesi; Immacolata Esposito; Ranadhir Punreddy; Roberto Da Cas; Giuseppe Traversa; Francesco Perrone; Nello Martini; Bishal Gyawali; Antonio Addis
Journal:  BMJ Open       Date:  2019-12-10       Impact factor: 2.692
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.